These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 36171609)

  • 1. Interpretation of the role of germline and somatic non-coding mutations in cancer: expression and chromatin conformation informed analysis.
    Pudjihartono M; Perry JK; Print C; O'Sullivan JM; Schierding W
    Clin Epigenetics; 2022 Sep; 14(1):120. PubMed ID: 36171609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mining the coding and non-coding genome for cancer drivers.
    Li J; Drubay D; Michiels S; Gautheret D
    Cancer Lett; 2015 Dec; 369(2):307-15. PubMed ID: 26433158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive Investigation of Genomic Variants in Prostate Cancer Reveals 30 Putative Regulatory Variants.
    Labani M; Beheshti A; Argha A; Alinejad-Rokny H
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OncoBase: a platform for decoding regulatory somatic mutations in human cancers.
    Li X; Shi L; Wang Y; Zhong J; Zhao X; Teng H; Shi X; Yang H; Ruan S; Li M; Sun ZS; Zhan Q; Mao F
    Nucleic Acids Res; 2019 Jan; 47(D1):D1044-D1055. PubMed ID: 30445567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.
    Zhu H; Uusküla-Reimand L; Isaev K; Wadi L; Alizada A; Shuai S; Huang V; Aduluso-Nwaobasi D; Paczkowska M; Abd-Rabbo D; Ocsenas O; Liang M; Thompson JD; Li Y; Ruan L; Krassowski M; Dzneladze I; Simpson JT; Lupien M; Stein LD; Boutros PC; Wilson MD; Reimand J
    Mol Cell; 2020 Mar; 77(6):1307-1321.e10. PubMed ID: 31954095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-associated variants in different categories of disease located in distinct regulatory elements.
    Ma M; Ru Y; Chuang LS; Hsu NY; Shi LS; Hakenberg J; Cheng WY; Uzilov A; Ding W; Glicksberg BS; Chen R
    BMC Genomics; 2015; 16 Suppl 8(Suppl 8):S3. PubMed ID: 26110593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating Germline and Somatic Mutation Information for the Discovery of Biomarkers in Triple-Negative Breast Cancer.
    Wu J; Mamidi TKK; Zhang L; Hicks C
    Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30909550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative modeling of eQTLs and cis-regulatory elements suggests mechanisms underlying cell type specificity of eQTLs.
    Brown CD; Mangravite LM; Engelhardt BE
    PLoS Genet; 2013; 9(8):e1003649. PubMed ID: 23935528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidden secrets of the cancer genome: unlocking the impact of non-coding mutations in gene regulatory elements.
    Iñiguez-Muñoz S; Llinàs-Arias P; Ensenyat-Mendez M; Bedoya-López AF; Orozco JIJ; Cortés J; Roy A; Forsberg-Nilsson K; DiNome ML; Marzese DM
    Cell Mol Life Sci; 2024 Jun; 81(1):274. PubMed ID: 38902506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the function of regulatory DNA interactions in the interpretation of non-coding GWAS variants.
    Zhong W; Liu W; Chen J; Sun Q; Hu M; Li Y
    Front Cell Dev Biol; 2022; 10():957292. PubMed ID: 36060805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CScape-somatic: distinguishing driver and passenger point mutations in the cancer genome.
    Rogers MF; Gaunt TR; Campbell C
    Bioinformatics; 2020 Jun; 36(12):3637-3644. PubMed ID: 32282885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.
    Zhang L; Xu M; Zhang W; Zhu C; Cui Z; Fu H; Ma Y; Huang S; Cui J; Liang S; Huang L; Wang H
    Cell Mol Biol Lett; 2023 Jan; 28(1):1. PubMed ID: 36609218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating germline and somatic variation information using genomic data for the discovery of biomarkers in prostate cancer.
    Mamidi TKK; Wu J; Hicks C
    BMC Cancer; 2019 Mar; 19(1):229. PubMed ID: 30871495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of germline and somatic missense variations on drug binding sites.
    Yan C; Pattabiraman N; Goecks J; Lam P; Nayak A; Pan Y; Torcivia-Rodriguez J; Voskanian A; Wan Q; Mazumder R
    Pharmacogenomics J; 2017 Mar; 17(2):128-136. PubMed ID: 26810135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of products of germ-line and somatic gene mutations on chromatin remodeling].
    Smardová J; Smarda J
    Cas Lek Cesk; 2002 Mar; 141(4):112-7. PubMed ID: 12046254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the exome: the role of non-coding somatic mutations in cancer.
    Piraino SW; Furney SJ
    Ann Oncol; 2016 Feb; 27(2):240-8. PubMed ID: 26598542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origins and characterization of variants shared between databases of somatic and germline human mutations.
    Meyerson W; Leisman J; Navarro FCP; Gerstein M
    BMC Bioinformatics; 2020 Jun; 21(1):227. PubMed ID: 32498674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
    Buckley AR; Ideker T; Carter H; Harismendy O; Schork NJ
    Genome Med; 2018 Sep; 10(1):69. PubMed ID: 30217226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in transcriptional networks in cancer: the role of noncoding somatic driver mutations.
    Doane AS; Elemento O
    Curr Opin Genet Dev; 2022 Aug; 75():101919. PubMed ID: 35609422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.